hengrui – Lab DB

Pharmaceutical R&D

Bristol Myers Squibb and Hengrui Pharma Forge Landmark $15.2 Billion Oncology and Immunology Collaboration

Teuku Ryan May 13, 2026 0

Bristol Myers Squibb (BMS) and Chinese biopharmaceutical giant Hengrui Pharma have announced a monumental licensing and collaboration agreement, potentially valued…

Novo Nordisk Expands Cardiometabolic Portfolio With $2.3bn Hengrui Licensing Deal for Once-Weekly Oral GLP-1/GIP Agonist HRS-1596

Bristol Myers Squibb and Hengrui Pharma Forge Landmark $15.2 Billion Oncology and Immunology Collaboration

YOU MAY HAVE MISSED

Stanford Physicists Directly Observe Quantum Jumps of Sound for the First Time in a Mechanical Resonator

Beyond Fuel: Stanford Study Reveals Glucose Acts as a Master Regulator of Cell Differentiation

The biotech bi-weekly: an expansion into cardiac drug discovery, the world’s largest healthy human protein atlas and large libraries of AI-designed proteins

Breakthrough Brain Imaging Study Links Long COVID to Dopamine Neuron Damage